GMO Beyond China ETF(BCHI)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$7.56
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for BCHI

11/20/2026: BCHI (1-star) is currently NOT-A-BUY. Pass it for now.

The GMO Beyond China ETF (BCHI) provides active exposure to emerging market equities while explicitly excluding Chinese securities, targeting countries positioned to benefit from global supply chain realignment. Its primary strengths lie in GMO's institutional valuation expertise and a thematic focus on nearshoring beneficiaries in nations like India, Mexico, and Vietnam. The fund serves as a targeted satellite allocation for portfolios seeking to bypass geopolitical risks tied to mainland China. Key risks include emerging market volatility, a higher active expense ratio of 0.65%, and modest asset scale relative to passive indexing giants. It best suits long-term investors looking for active risk mitigation, requiring close monitoring of relative performance and trade policy trends.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile exposed to fast-growing economies like India and Vietnam, the fund's underlying methodology incorporates strict valuation disciplines rather than pure growth chasing.
Momentum investorStrong fit while signal remains positiveThe strategy captures ongoing structural momentum in nearshoring and alternative emerging market outperformance as long as macro tailwinds persist.
Value investorStrong fitGMO's foundational value-oriented philosophy aligns well with investors seeking reasonably priced companies outside crowded markets.
Dividend/Income investorWeak fitThe fund prioritizes total capital appreciation and strategic positioning over high current dividend distributions.
Low-risk investorWeak fitEmerging market equities carry inherent currency, political, and operational volatility that conflicts with low-risk mandates.

Investor Profile

Ideal Investor Profile

Long-term investors seeking actively managed exposure to developing economies while intentionally avoiding Chinese market risks.

Suitability

Best suited for tactical long-term allocators who value GMO's valuation discipline and wish to capture structural manufacturing shifts.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMedium / highEmerging market equities routinely experience sharp price swings driven by local economic cycles and global sentiment.
Market riskHighUnfavorable global macroeconomic shifts or trade policy shocks can directly impact developing market equity prices.
ConcentrationMedium / highThe fund holds a focused basket of 70 to 100 securities, increasing stock-specific exposure relative to broad index funds.
Tracking/expenseMediumAn active expense ratio of 0.65% requires the management team to generate consistent alpha to outperform cheaper passive alternatives.
LiquidityMediumModest assets under management can translate to wider trading spreads during periods of market stress.
Business/sector qualityMediumUnderlying companies operate across diverse regulatory jurisdictions with varying corporate governance standards.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

BCHI experiences moderate-to-high historical volatility consistent with broader international equity markets and concentrated active allocations.

Market Risk

Subject to global trade disruptions, emerging market currency fluctuations, and localized geopolitical policy shifts.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
GeographyEmerging Markets Ex-China Equities (e.g., India, Taiwan, Mexico, Southeast Asia)98Provides diversified equity exposure to developing nations benefiting from global manufacturing relocation away from China.
Cash/collateralCash and Cash Equivalents2Maintains minimal liquidity liquidity buffer for operational efficiency and daily settlement.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type ETF
Historic Profit 36.62%
Avg. Invested days 135
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.